LNG-IUS: The best tool for non-surgical treatment of abnormal uterine bleeding and endometriosis

In: Indian Journal of Obstetrics and Gynecology Research · 2018 · vol. 5(1) , pp. 64–67 · doi:10.18231/2394-2754.2018.0014 · W3198052050
article OA: hybrid CC0 ⤵ 1 in-corpus citation
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This three-year study of 52 women found the levonorgestrel-releasing intrauterine system (LNG-IUS) effectively reduced menstrual blood loss by 85% at six months and achieved amenorrhea by two years for abnormal uterine bleeding.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-07 · read from full text ⓘ

This paper assessed the levonorgestrel-releasing intrauterine system (LNG-IUS) as a non-surgical treatment for abnormal uterine bleeding and endometriosis in 52 women aged 32–55 followed for three years. The authors report an 85% decrease in menstrual blood loss at 6 months and complete amenorrhea by two years, along with better compliance and satisfaction with the LNG-IUS. The main limitation is that the study is presented without a control group or detailed methodology, limiting causal interpretation. This paper is centrally about endometriosis — it evaluates LNG-IUS for non-surgical management of both abnormal uterine bleeding and endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Introduction: The levonorgestrel- releasing intrauterine system (LNG-IUS) is the best tool for the non-surgical treatment for uterine bleeding and endometriosis. Materials and methods: Fifty-two women between the age 32 – 55 years were studied over a period of three years. Results: LNG-IUS caused 85% decrease in the amount of menstrual blood loss at 6 month and complete amenorrhea at two years. Conclusion: LNG-IUS was the best and effective to surgical management and other modes of medical treatment of abnormal uterine bleeding. The patient showed better compliance and satisfaction to the LNG-IUS. Keywords: Levonorgestrel-releasing intrauterine system (LNG-IUS), Abnormal Uterine Bleeding (AUB).
Full text 1,861 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Introduction

The levonorgestrel- releasing intrauterine system (LNG-IUS) is the best tool for the non-surgical treatment for uterine bleeding and endometriosis. Materials and methods: Fifty-two women between the age 32 – 55 years were studied over a period of three years. Results: LNG-IUS caused 85% decrease in the amount of menstrual blood loss at 6 month and complete amenorrhea at two years. Conclusion: LNG-IUS was the best and effective to surgical management and other modes of medical treatment of abnormal uterine bleeding. The patient showed better compliance and satisfaction to the LNG-IUS.

Keywords

Levonorgestrel-releasing intrauterine system (LNG-IUS), Abnormal Uterine Bleeding (AUB). × How to Cite This Article Vancouver Benipal KR, Pal A, Thakur M, Sharma A, Sharma A. LNG-IUS: The best tool for non-surgical treatment of abnormal uterine bleeding and endometriosis [Internet]. Indian J Obstet Gynecol Res. 2018 [cited 2026 Jun 07];5(1):64-67. Available from: https://doi.org/10.18231/2394-2754.2018.0014 APA Benipal, K. R., Pal, A., Thakur, M., Sharma, A., Sharma, A. (2018). LNG-IUS: The best tool for non-surgical treatment of abnormal uterine bleeding and endometriosis. Indian Journal of Obstetrics and Gynecology Research, 5(1), 64-67. https://doi.org/10.18231/2394-2754.2018.0014 MLA Benipal, Keshav Ram, Pal, Anita, Thakur, Manish, Sharma, Anoop, Sharma, Atul. "LNG-IUS: The best tool for non-surgical treatment of abnormal uterine bleeding and endometriosis." Indian J Obstet Gynecol Res, vol. 5, no. 1, 2018, pp. 64-67. https://doi.org/10.18231/2394-2754.2018.0014 Chicago Benipal, K. R., Pal, A., Thakur, M., Sharma, A., Sharma, A.. "LNG-IUS: The best tool for non-surgical treatment of abnormal uterine bleeding and endometriosis." Indian J Obstet Gynecol Res 5, no. 1 (2018): 64-67. https://doi.org/10.18231/2394-2754.2018.0014

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

Cited by (1)

References (11)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK